Physician profile

Tracy E Collins

Family · New Orleans, LA

NPI 1922309533

$414.87

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$290.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Dexcom, INC. $154.25 2024 Dexcom G7 Gss (161)
Urogen Pharma, INC. $61.38 2023-2024 Jelmyto
Janssen Biotech, INC. $47.90 2022
Daiichi Sankyo INC. $43.25 2023 Enhertu
Axonics, INC. $41.85 2022
Myriad Genetic Laboratories, INC. $33.57 2021-2023 Prolaris
Endo Pharmaceuticals INC. $18.87 2022
Novartis Pharmaceuticals Corporation $13.80 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tracy E Collins

$414.87

in general payments reported 2019-2025

Years
2021-2024
Top company
Dexcom, INC.

https://glasscript.com/doctor/223189/tracy-e-collins

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.